Market Analysis — CENTRO COMPRENSIVO DE CANCER
PR market | 3 hospitals | HHI: 3,526 (Concentrated)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
3
Hospitals in Market
378
Total Beds
$0.1B
Market Revenue
Concentrated
HHI: 3,526
None
Moat Rating (2/10)
#3
Market Share Rank
Competitive Moat (Mauboussin Framework)
Based on "Measuring the Moat" adapted for healthcare. Score 0-10: wide (8+), narrow (5-7), none (<5).
Scale Advantageweak
Switching Costslow
Market Share22.1%
Top 3 Concentration100.0%
Network Density0.79
Margin vs Market-13.6%
Bed Util vs Market-22.2%
What This Means
This hospital has a none moat — no moat — commoditized market position, pricing power limited. The PR market is highly concentrated — few dominant players, potential antitrust concerns (HHI: 3,526).
Implications: Operational improvements are the primary value driver — see the EBITDA bridge. Compare against peers via comparables or see the full PR market.
Top Competitors
| Hospital | Beds | Revenue | Rev Share | Bed Share |
|---|---|---|---|---|
| SAN JUAN CP HOSPITAL | 165 | $37M | 40.2% | 43.6% |
| UNIVERSITY PEDIATRIC HOSPITAL | 165 | $35M | 37.7% | 43.6% |
Regional Payer Mix
■ Medicare 2%■ Medicaid 56%■ Commercial 42%